Concord Drugs Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹10.80Cr |
Net Profits | ₹0.23Cr |
Net Profit Margins | 2.13% |
Concord Drugs Ltd’s revenue fell -15.49% since last year same period to ₹10.80Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -12.69% fall in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 213.4% since last year same period to 2.13% in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 558.59% jump in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Drugs Ltd in Q3 results 2024?
The revenue for Concord Drugs Ltd in the Q3 results 2024 was ₹10.80Cr.
What was the net profit for Concord Drugs Ltd in Q3 results 2024?
The net profit for Concord Drugs Ltd in the Q3 results 2024 was ₹0.23Cr.
What was the net profit margin for Concord Drugs Ltd in Q3 results 2024?
The net profit margin for Concord Drugs Ltd in the Q3 results 2024 was 2.13%.
What was the revenue for Concord Drugs Ltd in Q3 results 2023?
The revenue for Concord Drugs Ltd in the Q3 results 2023 was ₹12.78Cr.
What was the net profit for Concord Drugs Ltd in Q3 results 2023?
The net profit for Concord Drugs Ltd in the Q3 results 2023 was ₹0.24Cr.
What was the net profit margin for Concord Drugs Ltd in Q3 results 2023?
The net profit margin for Concord Drugs Ltd in the Q3 results 2023 was -1.88%.
